PRINCE’s prospects: Statins, inflammation, and coronary risk

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 881-883

  Azar, Rabih R ^a,b   Waters, David D ^a,b  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

CORONARY ARTERY DISEASE; CORONARY RISK; EDITORIAL; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; PRIORITY JOURNAL;

EID: 0035020113     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.115298     Document Type: Article

References (21)

1. CJ Vaughn AM Gotto CT. Basson The evolving role of statins in the management of atherosclerosis J Am Coll Cardiol 35 2000 1 10
2. Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
3. CB Treasure L Klein WS Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
4. L Lacoste JYT Lam J Hung Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction Circulation 92 1995 3172 3177
5. PM Ridker N Rifai MA Pfeffer Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
6. PM Ridker M Cushman MJ Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
7. G Liuzzo LM Biasucci JR Gallimore The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 1994 417 424
8. LM Biasucci G Liuzzo RL Grillo Elevated levels of C-reactive protein at discharge in patients with unstable angina predicts recurrent instability Circulation 99 1999 855 860
9. RR Azar S Rinfret P Theroux A randomized placebocontrolled trial to assess the efficacy of anti-inflammatory therapy with methylprednisolone in unstable angina Eur Heart J 21 2000 2026 2032
10. A Maseri Inflammation, atherosclerosis, and ischemic events—exploring the hidden side of the moon N Engl J Med 336 1997 1014 1016
11. J Mehta J Dinerman P Mehta Neutrophil function in ischemic heart disease Circulation 79 1989 549 556
12. A Mazzone S DeServi G Ricevuti Increased expression of neutrophil and moncyte adhesion molecules in unstable coronary artery disease Circulation 88 1993 358 363
13. H Kai H Ikeda H Yasukawa Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J Am Coll Cardiol 32 1998 368 372
14. PM Ridker CH Hennekens JE Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
15. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
16. AC Van der Wal AE Becker CM van der Loos Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
17. RS Rosenson CC. Tangney Antiatherosclerotic properties of statins JAMA 279 1998 1643 1650
18. J Davignon R. Laaksonen Low-density lipoprotein-independent effects of statins Curr Opin Lipidol 10 1999 543 559
19. PM Ridker N Rifai JS Miles Lovastatin 20-40 mg/day lowers high-sensitivity C-reactive protein levels in AFCAPS/TexCAPS [abstract] Circulation 102 2 Suppl 2000 II833
20. I Jialal D Stein D Balis Effect of HMG-CoA reductase inhibitors on C-reactive protein levels [abstract] Circulation 102 2 Suppl 2000 II833
21. C Weber W Erl KSC Weber HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia J Am Coll Cardiol 30 1997 1212 1217